Stat News
Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctor
Deepfakes are no longer just a political or entertainment problem — they are arriving in healthcare, where a convincing fake physician can extract sensitive information or manipulate patients into dangerous decisions. The threat cuts to the core of telehealth, a system built entirely on trust in what patients see and hear through a screen. When that trust is compromised, the legitimacy of digital medicine itself begins to collapse.
Read article →Medical Xpress
Underregulated dietary supplements endanger public health, say experts
The American College of Physicians is calling for sweeping reforms to how dietary supplements are manufactured and marketed, warning that the current regulatory framework falls short of protecting public health. In a position paper published in *Annals of Internal Medicine*, the ACP outlines specific recommendations to modernize oversight of an industry that millions of Americans rely on daily. The push reflects growing concern among physicians that supplements face far less scrutiny than the drugs they often sit alongside on pharmacy shelves.
Read article →Medical Xpress
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
A clinical trial has found that a THC/CBD formulation significantly reduced agitation in dementia patients nearing end of life, outperforming placebo in what researchers describe as a first-of-its-kind study. Agitation is one of the most distressing and difficult-to-manage symptoms in late-stage dementia, affecting both patients and caregivers. The findings could open a new treatment avenue at a stage where existing options are limited and often inadequate.
Read article →
Stat News
FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist
A former FDA toxicologist is alleging the agency greenlit Zyn nicotine pouches without conducting a complete review of the product's ingredients or manufacturing process. The accusation raises serious questions about the rigor of the FDA's premarket tobacco authorization pathway, which is meant to ensure new nicotine products meet a public health standard. With Zyn already dominating the U.S. nicotine pouch market, the stakes for both regulators and consumers are high.
Read article →Medical Xpress
Combination treatment harnesses cellular recycling system to fight multiple myeloma
Researchers at VCU Massey Comprehensive Cancer Center have identified a combination treatment strategy that leverages the cell's natural waste-removal machinery to attack multiple myeloma. The experimental protein degrader targets a key cancer cell survival protein and demonstrated enhanced effectiveness when paired with existing drugs in preclinical models. Notably, the approach showed limited cardiac toxicity, a critical consideration in advancing potential therapies toward clinical use.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →